Elsevier

Cortex

Volume 73, December 2015, Pages 36-61
Cortex

Review
Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease?

https://doi.org/10.1016/j.cortex.2015.07.032Get rights and content

Abstract

Behavioural and Psychological Symptoms of Dementia (BPSD) are a core symptom of dementia and are associated with suffering, earlier institutionalization and accelerated cognitive decline for patients and increased caregiver burden. Despite the extremely high risk for Down syndrome (DS) individuals to develop dementia due to Alzheimer's disease (AD), BPSD have not been comprehensively assessed in the DS population. Due to the great variety of DS cohorts, diagnostic methodologies, sub-optimal scales, covariates and outcome measures, it is questionable whether BPSD have always been accurately assessed. However, accurate recognition of BPSD may increase awareness and understanding of these behavioural aberrations, thus enabling adaptive caregiving and, importantly, allowing for therapeutic interventions. Particular BPSD can be observed (long) before the clinical dementia diagnosis and could therefore serve as early indicators of those at risk, and provide a new, non-invasive way to monitor, or at least give an indication of, the complex progression to dementia in DS. Therefore, this review summarizes and evaluates the rather limited knowledge on BPSD in DS and highlights its importance and potential for daily clinical practice.

Section snippets

Introduction: Down syndrome (DS) and Alzheimer's disease (AD) – a disruptive marriage

Intellectual disability, previously referred to as mental retardation, is defined as ‘a significantly reduced ability to understand new or complex information and to learn and apply new skills’ (World Health Organization, 2014) and reaches a prevalence of approximately 1% in the Western population (Maulik, Mascarenhas, Mathers, Dua, & Saxena, 2011). The most common genetic cause of human intellectual disability is DS, caused by the triplication of the human chromosome 21 (HSA21). DS, or trisomy

BPSD

BPSD, or in a narrower sense also known as neuropsychiatric symptoms (NPS), are defined as ‘a heterogeneous range of psychological reactions, psychiatric symptoms and behaviours resulting from the presence of dementia’ (Finkel, 2001, Lyketsos et al., 2011). Even though BPSD have been intensively studied during the last two decades, they are far from being a newly recognized entity. Already in 1906, Alois Alzheimer described hallucinations, delusions, paranoia and agitation in his famous 51-year

Diagnosis of BPSD in DS: a challenging endeavour

Whereas the dementia field largely uses the terminology of BPSD or NPS to address behavioural and psychological changes, reports on demented DS subjects referred to them in numerous ways: from behavioural disturbances (Prasher & Filer, 1995), behavioural changes (Adams et al., 2008, Duggan et al., 1996), behavioural deficits and excesses (Adams and Oliver, 2010, Adams et al., 2008, Millichap et al., 2003) to psychiatric symptoms (Moss and Patel, 1995, Urv et al., 2010), maladaptive behaviour (

Cross-sectional approaches

The first paper to report on BPSD in a series of demented DS individuals was published by Dalton and Crapper-McLachlan (1986). They summarized a total of 35 reported cases that were described between 1946 and 1985. Neuropathological confirmation of AD was available in 33 cases. Clinical dementia was present in 25 individuals. Common reported features were personality changes and apathy/inactivity (Table 2), while depression, disorientation and hallucinations/delusions were less prevalent.

Behavioural and psychological phenotypes in DS

Since Langdon Down's ‘Observations on an Ethnic Classification of Idiots’ (1866) and Mitchell's notes on sixty-two cases of ‘kalmuc idiots’ (1876), clinicians and researchers have tried to describe and define a typical behavioural phenotype of DS (Collacott et al., 1998, Down, 1995, Fraser and Mitchell, 1876). Is there indeed a characteristic behavioural phenotype of DS, and if so, which recurrent symptoms are generally present? Such pre-morbid symptoms are particularly relevant to take into

Clinical implications and future perspectives

BPSD are associated with increased suffering, accelerated cognitive decline, earlier institutionalization and an increased mortality risk for patients, increased caregiver burden and higher costs (Finkel, 2000). In that context, accurate and early recognition of BPSD in DS may increase awareness and expand our understanding of the behavioural aberrations, thus enabling adaptive caregiving and, importantly, allowing for therapeutic interventions.

However, assessment of BPSD in DS is currently

Neurobiology of BPSD in DS

Unravelling the underlying neurobiological mechanisms of BPSD in DS would contribute to the general understanding of these burdensome behavioural and psychological changes and aid the development of targeted therapeutic, and possibly preventive, interventions. An increasing number of studies addressed the mechanisms of BPSD in AD, for instance pointing at specific dysregulated monoaminergic neurotransmitter systems (Vermeiren et al., 2014a, Vermeiren et al., 2014b). In agreement, we recently

Conclusion

In conclusion, BPSD are a core symptom of dementia in addition to cognitive decline and impaired activities of daily living, and are extensively studied in MCI and AD patients in the general population. Despite the extremely high risk to develop AD and the lack of early (bio)markers with limited invasiveness to predict the onset of AD in DS, most dementia research in the DS population did not comprehensively assess BPSD. The great variety of cohorts, diagnostic methodologies, covariates and

Conflict of interest

The authors herein declare no conflict of interest.

Acknowledgements

This work was supported by the Alzheimer Research Center of the University Medical Center Groningen (UMCG), a subsidy from the Gratama-Stichting/Stichting Groninger Universiteitsfonds (2015-04), the Interuniversity Poles of Attraction (IAP Network P7/16) of the Belgian Federal Science Policy Office, a Methusalem excellence grant of the Flemish Government, agreement between Institute Born-Bunge and University of Antwerp, the Medical Research Foundation Antwerp, the Thomas Riellaerts research

References (176)

  • C. Lyketsos et al.

    Neuropsychiatric symptoms in Alzheimer's disease

    Alzheimer’s & Dementia

    (2011)
  • A.T. Makary et al.

    The association between behavioural and emotional problems and age in adults with Down syndrome without dementia: examining a wide spectrum of behavioural and emotional problems

    Research in Developmental Disabilities

    (2014)
  • D. Adams et al.

    The relationship between acquired impairments of executive function and behaviour change in adults with Down syndrome

    Journal of Intellectual Disability Research

    (2010)
  • D. Adams et al.

    Behavioural characteristics associated with dementia assessment referrals in adults with Down syndrome

    Journal of Intellectual Disability Research

    (2008)
  • Alzheimer's Assocation

    2015 Alzheimer's disease facts and figures

    Alzheimer's & Dementia

    (2015)
  • S.R. Auer et al.

    The empirical behavioral pathology in Alzheimer's disease (E-BEHAVE-AD) rating scale

    International Psychogeriatrics/IPA

    (1996)
  • E.H. Aylward et al.

    Diagnosis of dementia in individuals with intellectual disability

    Journal of Intellectual Disability Research

    (1997)
  • C. Ballard et al.

    Agitation and aggression in people with Alzheimer's disease

    Current Opinion in Psychiatry

    (2013)
  • T.M. Ballard et al.

    RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors

    Psychopharmacology

    (2009)
  • S.L. Ball et al.

    Personality and behaviour changes mark the early stages of Alzheimer's disease in adults with Down's syndrome: findings from a prospective population-based study

    International Journal of Geriatric Psychiatry

    (2006)
  • S.L. Ball et al.

    The CAMDEX-DS: The Cambridge examination for mental disorders of older people with Down's syndrome and others with intellectual disabilities

    (2006)
  • S.L. Ball et al.

    The modified CAMDEX informant interview is a valid and reliable tool for use in the diagnosis of dementia in adults with Down's syndrome

    Journal of Intellectual Disability Research

    (2004)
  • S.L. Ball et al.

    Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities

    The British Journal of Clinical Psychology/The British Psychological Society

    (2008)
  • S.L. Ball et al.

    Theoretical exploration of the neural bases of behavioural disinhibition, apathy and executive dysfunction in preclinical Alzheimer's disease in people with Down's syndrome: potential involvement of multiple frontal-subcortical neuronal circuits

    Journal of Intellectual Disability Research

    (2010)
  • F. Beacher et al.

    Brain anatomy and ageing in non-demented adults with Down's syndrome: an in vivo MRI study

    Psychological Medicine

    (2010)
  • D.W. Beebe et al.

    Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits

    Journal of Sleep Research

    (2002)
  • A.H. Bittles et al.

    The four ages of Down syndrome

    European Journal of Public Health

    (2007)
  • N. Bouras et al.

    Psychiatric and behavioural disorders in intellectual and developmental disabilities

    (2007)
  • J.H. Breslin et al.

    Parental report of sleep problems in Down syndrome

    Journal of Intellectual Disability Research

    (2011)
  • D.B. Burt et al.

    Depression and the onset of dementia in adults with mental retardation

    American Journal of Mental Retardation

    (1992)
  • G.T. Capone et al.

    Adolescents and young adults with Down syndrome presenting to a medical clinic with depression: co-morbid obstructive sleep apnea

    American Journal of Medical Genetics. Part A

    (2013)
  • G.T. Capone et al.

    Neurobehavioral disorders in children, adolescents, and young adults with Down syndrome

    American Journal of Medical Genetics. Part C, Seminars in Medical Genetics

    (2006)
  • M. Carter et al.

    Sleep problems in a Down syndrome population

    Archives of Disease in Childhood

    (2009)
  • L. Charlot et al.

    Obsessional slowness in Down's syndrome

    Journal of Intellectual Disability Research

    (2002)
  • T.-W. Cheng et al.

    Comparison of behavioral and psychological symptoms of Alzheimer's disease among institution residents and memory clinic outpatients

    International Psychogeriatrics

    (2009)
  • R.A. Collacott et al.

    Behaviour phenotype for Down's syndrome

    The British Journal of Psychiatry: The Journal of Mental Science

    (1998)
  • R.A. Collacott et al.

    Differential rates of psychiatric disorders in adults with Down's syndrome compared with other mentally handicapped adults

    The British Journal of Psychiatry: The Journal of Mental Science

    (1992)
  • S.-A. Cooper et al.

    Clinical features and diagnostic criteria of depression in Down's syndrome

    The British Journal of Psychiatry: The Journal of Mental Science

    (1994)
  • S.-A. Cooper et al.

    Maladaptive behaviours and symptoms of dementia in adults with Down's syndrome compared with adults with intellectual disability of other aetiologies

    Journal of Intellectual Disability Research

    (1998)
  • S.-A. Cooper et al.

    Adults with intellectual disabilities: prevalence, incidence and remission of aggressive behaviour and related factors

    Journal of Intellectual Disability Research

    (2009)
  • A.M.W. Coppus et al.

    Dementia and mortality in persons with Down's syndrome

    Journal of Intellectual Disability Research

    (2006)
  • M.P. Cosgrave et al.

    Determinants of aggression, and adaptive and maladaptive behaviour in older people with Down's syndrome with and without dementia

    Journal of Intellectual Disability Research

    (1999)
  • J.-C. Cossec et al.

    Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes

    Human Molecular Genetics

    (2012)
  • E. Cumbo et al.

    Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial

    Journal of Alzheimer's Disease: JAD

    (2014)
  • J.L. Cummings

    The neuropsychiatric inventory: assessing psychopathology in dementia patients

    Neurology

    (1997)
  • J.L. Cummings et al.

    The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia

    Neurology

    (1994)
  • P.P. De Deyn et al.

    The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer's disease

    International Journal of Geriatric Psychiatry

    (2005)
  • P.P. De Deyn et al.

    A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia

    Neurology

    (1999)
  • P.P. De Deyn et al.

    Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia

    The Journal of Clinical Psychiatry

    (2001)
  • G. De Kuijper et al.

    Effects of controlled discontinuation of long-term used antipsychotics for behavioural symptoms in individuals with intellectual disability

    Journal of Intellectual Disability Research

    (2014)
  • Cited by (63)

    • Psychiatric issues in aging and dementia

      2021, The Neurobiology of Aging and Alzheimer Disease in Down Syndrome
    • Essentials of Neuropsychology: Integrating Eastern and Western Perspectives

      2024, Essentials of Neuropsychology: Integrating Eastern and Western Perspectives
    View all citing articles on Scopus
    View full text